![Joe D. Lewis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joe D. Lewis
Corporate Officer/Principal bei The European Molecular Biology Laboratory
Aktive Positionen von Joe D. Lewis
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
The European Molecular Biology Laboratory | Corporate Officer/Principal | - | - |
Karriereverlauf von Joe D. Lewis
Ehemalige bekannte Positionen von Joe D. Lewis
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
The University of Edinburgh | Corporate Officer/Principal | 01.01.1996 | - |
Anadys Pharmaceuticals, Inc.
![]() Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Corporate Officer/Principal | - | - |
Elara Pharmaceuticals GmbH
![]() Elara Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Elara Pharmaceuticals GmbH focuses on the development of novel treatments for malignant diseases. It has developed three distinct and proprietary dual mechanism chemotypes that potently inhibit the HIF signaling pathway and induce apoptosis. The firm has identified compounds with excellent in vitro activity against a diverse set of tumor cell lines and superior pharmacokinetic and toxicity profiles in vivo. The company was founded by Frank Gannon, Joe D. Lewis and George Reid on July 27, 2006 and is headquartered in Heidelberg, Germany. | Vorstandsvorsitzender | 27.07.2006 | - |
Gründer | 27.11.2009 | - |
Ausbildung von Joe D. Lewis
University of Vienna | Doctorate Degree |
Statistik
International
Deutschland | 3 |
Österreich | 2 |
Vereinigte Staaten | 2 |
Operativ
Corporate Officer/Principal | 3 |
Chief Executive Officer | 1 |
Founder | 1 |
Sektoral
Consumer Services | 4 |
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Elara Pharmaceuticals GmbH
![]() Elara Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Elara Pharmaceuticals GmbH focuses on the development of novel treatments for malignant diseases. It has developed three distinct and proprietary dual mechanism chemotypes that potently inhibit the HIF signaling pathway and induce apoptosis. The firm has identified compounds with excellent in vitro activity against a diverse set of tumor cell lines and superior pharmacokinetic and toxicity profiles in vivo. The company was founded by Frank Gannon, Joe D. Lewis and George Reid on July 27, 2006 and is headquartered in Heidelberg, Germany. | Health Technology |
Anadys Pharmaceuticals, Inc.
![]() Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Health Technology |
- Börse
- Insiders
- Joe D. Lewis
- Erfahrung